Crescent Biopharma Inc.

CBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.94

-$0.54 (-4.01%)

Nov 2, 2026, 12:38 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	213.19M	34.77M	41.79M	47.87M	90.25M	137.04M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.32M	813K	757.91K	344.71K	1.61M	1.61M
Receivables	18M	n/a	175.82K	144.02K	1.35K	2.15K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.28M	38K	n/a	n/a	n/a	n/a
Total Current Assets	236.66M	34.8M	43.79M	50.71M	90.79M	138.27M
Property-Plant & Equipment	2.32M	n/a	767.83K	751.17K	1.95M	2.95M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.64M	813K	1.53M	1.1M	3.56M	4.56M
Total Assets	240.29M	35.62M	45.32M	51.81M	94.35M	142.83M
Account Payables	10M	107K	868.12K	970.19K	2.11M	2.09M
Deferred Revenue	4.16M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	10.12M	76K	2.96M	2.97M	2.5M	3.91M
Total Current Liabilities	36.07M	9.61M	6.84M	8.88M	11.82M	12.43M
Long-Term Debt	n/a	37.48M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	4M	n/a	n/a	n/a	264.33K
Total Long-Term Liabilities	1.21M	41.48M	66.84K	n/a	918.61K	2.18M
Total Liabilities	37.28M	51.1M	6.9M	8.88M	12.74M	14.61M
Total Debt	1.64M	37.48M	808.4K	918.56K	1.92M	2.82M
Book Value	203.01M	-15.48M	38.41M	42.93M	81.6M	128.22M
Book Value Per Share	19.49	-20.17	60.65	81.72	158.60	280.44
Common Stock	28K	1K	64.39K	54.38K	52.31K	49.02K
Retained Earnings	-171.81M	-17.87M	-456.49M	-419.59M	-372.9M	-309.47M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	203.01M	-15.48M	38.41M	42.93M	81.6M	128.22M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a